Skip to main navigation
Header Menu
  • About Us
    • Who We Are
    • Our Team
    • Board of Directors
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
    • Clinical Trials
    • Research
  • Products
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
    • Pear Prescription Digital Therapeutics (PDT) Digest
  • Investors
    • IR Home
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Top Links
Contact Us
Pear Therapeutics, Inc.

News Releases

IR Sub Menu - News & Events
News ReleasesEvents & Presentations

News Releases

  • Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 2, 2023
  • Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders January 26, 2023
  • Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List January 18, 2023
  • Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series January 17, 2023
  • California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program January 12, 2023
  • Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics January 10, 2023
  • Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States January 4, 2023
Pear Therapeutics, Inc.
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
Footer Email
  • Email Us
Footer Social
  • Twitter
  • LinkedIn
  • © 2023 Pear Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct